CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-10 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −15,000 | 65,000 | ||
| 2018-09-04 | GILMAN STEVEN C Director | Option exercise | +9,000 | $2.63 | $24K | 9,000 |
| 2018-09-04 | GILMAN STEVEN C Director | Sale | −9,000 | $12.03 | $108K | 0 |
| 2018-09-04 | GILMAN STEVEN C Director | Option exercise · Stock Option (right to buy) | −9,000 | 8,500 | ||
| 2018-08-03 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise | +45,000 | $4.36 | $196K | 83,479 |
| 2018-08-03 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise | +67,481 | $3.02 | $204K | 150,960 |
| 2018-08-03 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | +45,000 | 0 | ||
| 2018-08-03 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | +67,481 | 112,519 | ||
| 2018-06-18 | Wotton Paul K Director | Option exercise | +5,000 | $3.74 | $19K | 5,000 |
| 2018-06-18 | Wotton Paul K Director | Option exercise | +10,000 | $2.76 | $28K | 15,000 |
| 2018-06-18 | Wotton Paul K Director | Option exercise | +15,000 | $3.74 | $56K | 30,000 |
| 2018-06-18 | Wotton Paul K Director | Sale | −10,000 | $12.06 | $121K | 20,000 |
| 2018-06-18 | Wotton Paul K Director | Sale | −15,000 | $12.06 | $181K | 5,000 |
| 2018-06-18 | Wotton Paul K Director | Sale | −5,000 | $12.06 | $60K | 0 |
| 2018-06-18 | Wotton Paul K Director | Option exercise · Stock Option (right to buy) | −5,000 | 0 | ||
| 2018-06-18 | Wotton Paul K Director | Option exercise · Stock Option (right to buy) | −10,000 | 5,000 | ||
| 2018-06-18 | Wotton Paul K Director | Option exercise · Stock Option (right to buy) | −15,000 | 0 | ||
| 2018-05-17 | Colangelo Dominick President and CEO | Sale | −20,000 | $14.01 | $280K | 53,085 |
| 2018-05-17 | Colangelo Dominick President and CEO | Option exercise | +10,000 | $2.75 | $28K | 63,085 |
| 2018-05-17 | Colangelo Dominick President and CEO | Option exercise | +1,548 | $3.02 | $5K | 64,633 |
Page 63 of 75 · 1,497 trades